Borgeson Blake
SEC insider (Form 3/4/5 filer). CIK 0001856094. Director at RECURSION PHARMACEUTICALS, INC. (RXRX). 21 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in SALT LAKE CITY, UT.
Companies Borgeson Blake has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director
Borgeson Blake
CIK: 0001856094
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RECURSION PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Oct 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect50K shares at avg. $4.84$242K - Sep 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect30K shares at avg. $3.34$100K - Aug 4, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect30K shares at avg. $3.25$98K - Jul 7, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect40K shares at avg. $3.96$159K - Jun 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect88.4K shares- - Jun 2, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect30K shares at avg. $3.68$110K - May 5, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect30K shares at avg. $3.52$106K - Apr 7, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect30K shares at avg. $3.10$93K - Mar 3, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect170K shares at avg. $3.46$588K - Feb 3, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect220K shares at avg. $4.20$924K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 50,000 | $4.84 | $242,000 | Direct |
| Sep 1, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 30,000 | $3.34 | $100,200 | Direct |
| Aug 4, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 30,000 | $3.25 | $97,500 | Direct |
| Jul 7, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 40,000 | $3.96 | $158,500 | Direct |
| Jun 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 88,424 | - | $0 | Direct |
| Jun 2, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 30,000 | $3.68 | $110,400 | Direct |
| May 5, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 30,000 | $3.52 | $105,600 | Direct |
| Apr 7, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 30,000 | $3.10 | $93,000 | Direct |
| Mar 3, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 170,000 | $3.46 | $588,200 | Direct |
| Feb 3, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 220,000 | $4.20 | $924,000 | Direct |
1-10 of 21 transactions